IAS (International AIDS Society) Conference

The Latest

This Week in HIV Research: Injectable PrEP Shows Promise in New Study

This week, a study finds that injectable cabotegravir, an investigational integrase inhibitor, is well tolerated and shows promise as pre-exposure prophylaxis (PrEP).

By Warren Tong and Barbara Jungwirth

How Can Science Help End HIV-Related Travel Restrictions? (Video)

These restrictions have no proven public-health benefit -- and can, in fact, shroud nations in a false sense of assurance that such bans, and not sound health policy, will keep HIV in their countries.

By Olivia G. Ford

Research on Two Supplements Addresses HIV-Driven Inflammation in the Gut -- A Blog Entry by Jeannie Wraight

"Gastrointestinal (GI) health is proving to be a vital, though often ignored, component of HIV infection."

By Jeannie Wraight

Normal Life Expectancy Seen for North Americans With HIV

People living with HIV in North America who receive antiretroviral therapy have improving -- near normal, in fact -- life expectancy, according to new data presented at IAS 2013.

Investigators from the NA-ACCORD presented the results of their analys...

By Josep M. Llibre, M.D., Ph.D. and Benjamin Young, M.D., Ph.D.

Detectable HIV May Be in Semen Despite Viral Suppression in Blood

Roughly one out of every 13 gay men in a recent study had detectable HIV in their semen but an undetectable viral load in their bloodstream.

By Warren Tong

Life Expectancy for People Living With HIV Increases by 15 Years

Despite generally exciting findings, a new study notes that improvements in life expectancy varied widely by sex, race and other factors.

By Warren Tong